These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3084888)

  • 1. Variation in resource use within diagnosis-related groups. The effect of severity of illness and physician practice.
    McMahon LF; Newbold R
    Med Care; 1986 May; 24(5):388-97. PubMed ID: 3084888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DRGs and disease staging for reimbursing Medicare patients.
    Coffey RM; Goldfarb MG
    Med Care; 1986 Sep; 24(9):814-29. PubMed ID: 3093783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The University of Alabama Hospitals prepares for Medicare DRG reimbursement.
    Moon JE
    Ala J Med Sci; 1984 Jan; 21(1):16-7. PubMed ID: 6422783
    [No Abstract]   [Full Text] [Related]  

  • 4. Severity of illness and DRG reimbursement.
    Newman RG; Stefanu C; Chassie MB; Pate ML; Anderson RJ
    Tex Med; 1986 Apr; 82(4):34-6. PubMed ID: 3085256
    [No Abstract]   [Full Text] [Related]  

  • 5. Is compression occurring in DRG prices?
    Lave JR
    Inquiry; 1985; 22(2):142-7. PubMed ID: 3159670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trauma case mix and hospital payment: the potential for refining DRGs.
    MacKenzie EJ; Steinwachs DM; Ramzy AI; Ashworth JW; Shankar B
    Health Serv Res; 1991 Apr; 26(1):5-26. PubMed ID: 1901840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will DRG payments creep into all US health insurance plans?
    Korcok M
    Can Med Assoc J; 1984 Apr; 130(7):912-5. PubMed ID: 6423253
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of case-mix adjustment on admission-based reimbursement.
    Kinzer D; Warner M
    Health Serv Res; 1983; 18(2 Pt 1):209-32. PubMed ID: 6409840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the feasibility and usefulness of physician DRGs.
    Culler S; Ehrenfried D
    Inquiry; 1986; 23(1):40-55. PubMed ID: 2937728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bringing psychiatric patients into the Medicare prospective payment system: alternatives to DRGs.
    Mitchell JB; Dickey B; Liptzin B; Sederer LI
    Am J Psychiatry; 1987 May; 144(5):610-5. PubMed ID: 3107408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of diagnosis-related groups and severity of illness on reimbursement for central nervous system infections.
    Froehlich H; Jarvis WR
    J Pediatr; 1991 May; 118(5):693-7. PubMed ID: 1902255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of illness within DRGs. Homogeneity study.
    Horn SD; Horn RA; Sharkey PD; Chambers AF
    Med Care; 1986 Mar; 24(3):225-35. PubMed ID: 3081772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interhospital differences in severity of illness. Problems for prospective payment based on diagnosis-related groups (DRGs).
    Horn SD; Bulkley G; Sharkey PD; Chambers AF; Horn RA; Schramm CJ
    N Engl J Med; 1985 Jul; 313(1):20-4. PubMed ID: 3923354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the new trauma DRGs on reimbursement.
    Jacobs BB; Jacobs LM
    J Trauma; 1992 Oct; 33(4):495-502; discussion 502-3. PubMed ID: 1433393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of classification and payment system of in patient hospital admissions in the United States: introduction of Medicare Severity Diagnosis-Related Groups (MS-DRGs) and the Present On Admission (POA) indicator].
    Maurici M; Rosati E
    Ig Sanita Pubbl; 2007; 63(6):691-701. PubMed ID: 18216884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in patient routine costliness in U.S. psychiatric facilities.
    Cromwell J; Drozd EM; Gage B; Maier J; Richter E; Goldman HH
    J Ment Health Policy Econ; 2005 Mar; 8(1):15-28. PubMed ID: 15870482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial risk, hospital cost, and complications and comorbidities in medical non-complications and comorbidity-stratified diagnosis-related groups.
    Muñoz E; Rosner F; Friedman R; Sterman H; Goldstein J; Wise L
    Am J Med; 1988 May; 84(5):933-9. PubMed ID: 3129939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distributional implications of using relative prices in DRG payment systems.
    Thorpe KE
    Inquiry; 1987; 24(1):85-95. PubMed ID: 2951338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prospective payments on a tertiary care center receiving large numbers of critically ill patients by aeromedical transport.
    Thomas F; Larsen K; Clemmer TP; Burke JP; Orme JF; Napoli M; Christison E
    Crit Care Med; 1986 Mar; 14(3):227-30. PubMed ID: 3080276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.